791137-20-7 Usage
Description
5-Bromo-2,4-dichlorobenzoic acid is a chemical compound with the molecular formula C7H3BrCl2O2. It is a derivative of benzoic acid, characterized by its strong acid properties and white crystalline solid appearance. 5-broMo-2,4-dichloro benzoic acid is sparingly soluble in water and relatively stable under normal conditions, making it a versatile intermediate in various chemical processes.
Uses
Used in Chemical Synthesis:
5-Bromo-2,4-dichlorobenzoic acid is used as an intermediate in organic synthesis for the production of dyes, perfumes, and pharmaceuticals. Its unique chemical structure allows for the creation of a wide range of compounds with diverse applications.
Used in Agriculture:
In the agricultural industry, 5-bromo-2,4-dichlorobenzoic acid is used as a herbicide and pesticide. It effectively inhibits the growth of certain plants and microorganisms, making it a valuable tool for controlling unwanted vegetation and pests.
Used in Pharmaceutical Development:
Due to its strong acid properties, 5-bromo-2,4-dichlorobenzoic acid is utilized in the development of pharmaceuticals. It can be incorporated into the synthesis of various drugs, potentially leading to new treatments and therapies for a range of medical conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 791137-20-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,9,1,1,3 and 7 respectively; the second part has 2 digits, 2 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 791137-20:
(8*7)+(7*9)+(6*1)+(5*1)+(4*3)+(3*7)+(2*2)+(1*0)=167
167 % 10 = 7
So 791137-20-7 is a valid CAS Registry Number.
791137-20-7Relevant articles and documents
PHENYL AMINO PIPERIDINE mTORC INHIBITORS AND USES THEREOF
-
Paragraph 1099; 1097, (2018/05/24)
The present invention provides compounds, compositions thereof, and methods of using the same.
NOVEL C-ARYL GLUCOSIDE SGLT2 INHIBITORS AND PHARMACEUTICAL COMPOSITION COMPRISING SAME
-
Page/Page column 116, (2010/12/31)
A novel C-aryl glucoside compound, or a pharmaceutically acceptable salt or a prodrug thereof having an inhibitory activity against sodium-dependent glucose cotransporter 2 (SGLT2) being present in the intestine and kidney; and a pharmaceutical composition comprising the same as an active ingredient, which is useful for preventing or treating metabolic disorders, particularly, diabetes, are provided.